KRISTY LIEKFET: Open Payments
NPI 1275133175 · ATLANTIC CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $113 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $198 |
| Amgen Inc. | 2 | $134 |
| Lilly USA, LLC | 2 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Phadia US Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
Products named: REPATHA, AIRSUPRA, MOUNJARO, FARXIGA, TZIELD, AUSTEDO XR, VOQUEZNA, ImmunoCAP.
Industry payments across NJ — which companies pay providers there.
